Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

New Stock News | Jia Zhi Technology Submits Application to Hong Kong Stock Exchange

New Stock Outlook | Increase in revenue without increase in profit signifies multiple challenges, with the largest customer revenue share of Cloud Intelligence exceeding 90% in 2024.

Guotai Haitong: Insurance and securities companies all received increased allocations, optimistic about the non-bank opportunities following the influx of residential funds into the market.
New Stock News | Jia Zhi Technology Submits Application to Hong Kong Stock Exchange

New Stock Outlook | Increase in revenue without increase in profit signifies multiple challenges, with the largest customer revenue share of Cloud Intelligence exceeding 90% in 2024.

Guotai Haitong: Insurance and securities companies all received increased allocations, optimistic about the non-bank opportunities following the influx of residential funds into the market.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


